Showing results (361-370 of 383) with videos related to
Sort By:
Pageof 39
Science (New York, N.Y.)|April 16, 1998
Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humansO Vahava, R Morell, E D Lynch, et al.The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology TeamK M Pisters, R J Ginsberg, D J Giroux, et al.Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupB J Roth, D H Johnson, L H Einhorn, et al.The Oncologist|October 21, 2000
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue CoalitionG A Curt, W Breitbart, D Cella, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerR F DeVore, D H Johnson, J Crawford, et al.Clinical Nuclear Medicine|June 1, 1992
Staging lung carcinoma with a Tc-99m labeled monoclonal antibodyJ P Vansant, D H Johnson, D M O'Donnell, et al.International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology GroupR Komaki, C B Scott, W T Sause, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant TherapyJ H Schiller, S Adak, R H Feins, et al.Genomics|November 24, 1999
Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2Y Liang, A Wang, I A Belyantseva, et al.Pageof 39